| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| | 10-K | 10-K | 10-K |
| Revenues | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 |
| Selling, general and administrative [+] | 39.2 | 28.0 | 8.6 |
| General and administrative | 39.2 | 28.0 | 8.6 |
| Research and development | 44.0 | 23.4 | 12.6 |
| EBITDA [+] | -83.0 | -51.3 | -21.1 |
| EBITDA growth | 61.9% | 142.9% | |
| Depreciation and amortization | 0.2 | 0.1 | 0.1 |
| EBIT [+] | -83.2 | -51.4 | -21.2 |
| EBIT growth | 61.9% | 142.7% | |
| Other income (expense), net [+] | 11.7 | -8.9 | 1.6 |
| Gain (loss) on foreign currency transactions | 2.0 | -11.7 | -0.1 |
| Other non-operating income | 0.0 | 0.3 | 0.1 |
| Pre-tax income | -71.5 | -60.3 | -19.6 |
| Income taxes | 0.2 | 0.0 | 0.0 |
| Net income | -71.7 | -60.3 | -19.6 |
| |
| Basic EPS [+] | ($1.79) | ($3.55) | ($2.62) |
| Growth | -49.5% | 35.4% | |
| Diluted EPS [+] | ($1.79) | ($3.55) | ($2.62) |
| Growth | -49.5% | 35.4% | |
| |
| Shares outstanding (basic) [+] | 40.0 | 17.0 | 7.5 |
| Growth | 135.4% | 127.3% | |
| Shares outstanding (diluted) [+] | 40.0 | 17.0 | 7.5 |
| Growth | 135.4% | 127.3% | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |